Palliative Care Is Not Hospice. I Had to Learn That Twice.

The short version

• Palliative care is not hospice. It is specialist care for the symptoms and stress of a serious illness, given alongside treatment meant to cure or control the disease. You can receive it on day one, during chemotherapy, for years.
• A landmark trial changed the standard of care. Patients with newly diagnosed metastatic lung cancer who saw palliative care early reported better quality of life, had fewer depressive symptoms, received less aggressive treatment at the end of life, and lived longer.
• Guidelines now say to refer early. Oncology clinicians should refer people with advanced cancer to palliative care teams early in the disease course, alongside active cancer treatment.
• Most people have never heard of it. An estimated 71% of US adults had never heard the term. Worldwide, only about 14% of people who need it receive it.
• It is not only for cancer. Most adults who need palliative care have heart disease, lung disease, kidney failure, dementia, or another chronic illness.
• You can ask for it yourself. Skip to what to say to your doctor.

A question I did not think to ask changed my mother's life more than any scan I have ever read. It came from an AI tool, and it was five words long: have you considered palliative care?

I want to tell you about two moments, fifteen years apart, that taught me the same lesson. I needed both of them, which tells you something about how hard the lesson is for doctors to learn.

The first moment: a hospice night shift

I trained in urology before I switched to radiology. In the gap between the two, I moonlighted at a hospice and palliative care center. I took the shifts for practical reasons. What happened there rearranged how I think about medicine.

Up to that point my training had one shape. Find the disease early. Intervene. Chase the abnormal lab. Stay on top of the plan. I spent my intern and resident years in a low hum of anxiety, tracking numbers, terrified of missing something. It was all directed at the illness. I am not sure I ever asked a patient what a good day would look like for them.

At the hospice, none of that applied. Nobody was waiting on a result. Nobody was deciding whether to intervene. Every conversation started somewhere else: are you in pain, can you sleep, what is making this day hard, what do you want to be able to do. The whole apparatus was pointed at the person instead of the pathology.

I had spent years treating the disease the patient had. That was the first time I watched a team treat the patient who had the disease.

I carried that with me into radiology and mostly filed it under "formative experience." Then it came back.

The second moment: my mother's cough

Before anyone said the word cancer, my mother had a cough.

Not a polite cough. A relentless one that ran her days and then took her nights. The coughing brought on severe tension headaches. The headaches and the cough together destroyed her sleep. She was exhausted, in pain, and shrinking out of her own life, and all of it was happening before a single treatment decision had been made. Eventually that cough, along with other symptoms, led to a diagnosis of lung cancer.

I used to think of a cough as a clue. A finding that points toward a diagnosis. It took watching my mother to understand that for the person coughing, it is not a clue. It is the whole day.

The research says she was far from alone. In a study of 202 patients with lung cancer, between 57% and 67% had a cough, depending on which validated instrument was used. About 15% reported that coughing often or always disrupted their sleep, and half felt their cough was bad enough to need treatment in its own right. Cough was not associated with cancer stage or cell type. It is not a marker of how advanced the disease is. It is simply a symptom that makes life worse, and it goes underaddressed.

The question I did not know to ask

I am a physician, and I still found the diagnosis disorienting. Lung cancer is not my field. I was reading pathology reports as a daughter, not a radiologist.

So I used AI to prepare. I worked through OpenEvidence to understand what her specific pathology meant, which treatments were on the table, and what I should raise when we met the oncology team. I wanted to walk into that room able to ask real questions instead of nodding.

Among the things it surfaced was a referral to palliative care, upfront, at diagnosis.

My honest first reaction was a flinch. Palliative care sat in my mind where it sits in most people's minds: at the end, after the treatments stop working, next to the word hospice. I went looking for why the recommendation existed, and found a trial I should have known about already.

The trial that moved palliative care to the front of the line

In 2010, researchers randomized 151 patients with newly diagnosed metastatic non-small-cell lung cancer to one of two arms. One group received standard oncology care. The other received the same standard oncology care plus a palliative care team from the start. Same chemotherapy decisions, same oncologists. The only variable was an extra team focused on symptoms, coping, and what mattered to the patient.

The results, published in the New England Journal of Medicine, were not what most people expect.

Standard oncology care alone Plus early palliative care

One trial, 151 patients, metastatic non-small-cell lung cancer (Temel 2010). Compare the two bars within a panel, never across panels, since each panel uses its own scale. Every difference shown reached statistical significance, though the quality-of-life gap is modest in absolute terms: 6.5 points on a 136-point scale. This was a single-center study, and the survival finding in particular has not held up consistently in later pooled analyses. More on that below.

Less aggressive treatment at the end, and yet a longer median survival. Better mood. Better quality of life. Adding a team whose entire job was comfort did not trade away time. In this trial it came with more of it.

That finding reshaped practice. Fourteen years later, the 2024 ASCO guideline update puts it plainly: clinicians should refer patients with advanced solid tumors and blood cancers to specialized interdisciplinary palliative care teams beginning early in the disease course, alongside active treatment of the cancer. Not after. Alongside.

The picture in most people's heads is the old one

Here is the shift, drawn out. The top row is what almost everyone pictures when they hear the word. The bottom row is what the evidence supports and what guidelines now recommend.

The difference is the word "alongside." Palliative care is not what happens when treatment stops. It is a second team working in parallel with the first, from diagnosis onward. Hospice is a specific kind of palliative care for the last months of life. It is one part of the picture, not the whole of it.

The gap between those two rows is not a technicality. It is the reason people say no to something that would have helped them.

71%

Of US adults reported they had never heard of palliative care

Nationally representative survey, 3,445 adults (Trivedi 2019)

14%

Of people worldwide who need palliative care actually receive it

World Health Organization

34%

Of adults needing palliative care have cancer. Most have heart, lung, kidney or neurologic disease.

World Health Organization

What actually happened when we went

We had excellent oncologists. I want to be precise about this, because what follows is not a complaint. They were deep subspecialists doing genuinely cutting-edge work, and they were exactly who I wanted deciding what to do about the tumor.

The palliative care visit was a different kind of appointment entirely.

Nobody opened by talking about the cancer. They asked about the cough. They asked about the headaches. They asked what was happening at two in the morning when she could not stop coughing long enough to fall asleep. They asked what she used to do in a normal week that she had stopped doing.

Then they treated those things. Directly, as problems worth solving on their own terms.

The tension headaches improved. The cough at night improved. She started sleeping. And here is the part I keep turning over: she ended up with a better quality of life than she had in the months before the diagnosis, when the cough was running unchecked and nobody had named it as a target. Nothing about that came from shrinking a tumor. All of it came from treating symptoms as if they mattered.

It made a tremendous difference for her, and for all of us around her. I had read about this. I had even lived it once, at a hospice, fifteen years earlier. I still did not see it coming.

Now the part where I read the evidence critically

I am a radiologist. I look at data for a living and I am suspicious of a single glowing trial, including one that confirms something I now believe. So here is the honest state of the evidence, including where it is weaker than the enthusiasm suggests.

Quality of life and symptoms: this holds up. A meta-analysis in JAMA pooled 43 randomized trials covering 12,731 patients and found that palliative care was associated with meaningful improvements in quality of life and symptom burden at one to three months, plus consistent gains in advance care planning, patient and caregiver satisfaction, and lower health care use. When the authors restricted the analysis to the five trials at lowest risk of bias, the quality-of-life benefit shrank but stayed significant, while the symptom-burden benefit lost significance. A Cochrane review of seven trials in 1,614 people with advanced cancer reached a similar conclusion: real improvements in quality of life and symptom intensity, small in size, rated low certainty.

Survival: genuinely unsettled. The 2010 trial found longer median survival. A later trial comparing early versus delayed palliative care found one-year survival of 63% versus 48%, favoring the early group. But the JAMA meta-analysis found no significant association between palliative care and survival across all trials, and Cochrane rated the survival evidence very low certainty. My read: the quality-of-life case is settled and the longevity case is a plausible bonus that nobody should promise you. The reason to go is not that it might buy you months. The reason to go is that it will very likely make the months better.

It works beyond cancer. In a randomized trial of 150 patients with advanced heart failure, adding an interdisciplinary palliative care team to usual cardiology care produced clinically significant improvements in quality of life, depression, anxiety, and spiritual well-being at six months. Hospitalization and mortality did not change. Quality of life did.

Depression: mixed. The 2010 lung cancer trial found substantially fewer depressive symptoms. The Cochrane pooled analysis of five trials did not find a significant difference. Both things are in the literature and I am not going to pick the flattering one.

Why most people still do not get it

If the evidence is this consistent, the obvious question is why palliative care remains something families stumble into rather than something offered by default. Three reasons, all fixable.

The name. Most people have never heard the term, and many who have heard it think it means giving up. Awareness is lower in rural areas and lower among Hispanic respondents regardless of geography, which makes this an access problem, not just a vocabulary problem.

The workforce. There are not enough palliative care clinicians to see every eligible patient every month, which is the schedule most of the landmark trials used. This is stated openly as a barrier in the trial literature.

Distance and logistics. Monthly specialist visits are a real burden on a sick person and a working family.

The good news is that researchers went after the last two directly, and the results are encouraging. A trial of 1,250 patients across 22 cancer centers found that delivering early palliative care by secure video visits produced equivalent quality of life to delivering it in person. A separate trial of 507 patients tested a stepped model, where visits happen at key transition points rather than monthly, and patients step up to more intensive contact if their quality-of-life score drops. That model roughly halved the number of visits without giving up the quality-of-life benefit. Worth noting honestly: the stepped group spent fewer days in hospice, which the authors flagged rather than buried.

Between video delivery and stepped scheduling, the "we do not have the capacity" objection is losing its force.

If someone you love has a serious illness

This is the practical part. You do not have to wait to be offered palliative care. In most systems you can ask for it, and asking works.

What to say, and what to ask

• Ask directly: "Can we get a palliative care consult alongside treatment?" The word "alongside" does a lot of work. It signals you are not asking to stop treatment.
• Name the symptoms, not the diagnosis. Cough, pain, nausea, breathlessness, insomnia, anxiety, appetite. These are the targets. List the ones wrecking the day.
• Say what a good day would look like. Palliative teams build the plan around this, and most of us never get asked.
• Ask if it can be virtual. The evidence says video visits work as well as in person for this.
• Ask what the team covers: symptom management, mood, coordination between specialists, help for the caregiver, and planning conversations. It is usually a physician, nurse, social worker, and chaplain, not one person.
• Ask about coverage. Palliative care is a medical subspecialty billed like any other. Medicare, Medicaid, and most private plans cover it.
• If nobody has an answer, the Center to Advance Palliative Care runs a public provider directory searchable by ZIP code and setting.

One more note, from the daughter rather than the doctor. Bring someone to the appointment, and make sure the person who is sick gets asked the questions directly. My mother does not speak English as her first language. In every room we sat in, the risk was that the conversation would happen over her head and around her, between clinicians and the family member who could keep up. The palliative team was the one that consistently aimed the questions at her.

What I keep coming back to

The thing that took me two decades to absorb is that treating the disease and treating the person are not the same project, and doing one well does not accomplish the other. Our oncologists were excellent at the first. Nothing about their excellence produced a night of sleep.

Both projects are real. Both need someone assigned to them. The evidence says running them in parallel from day one makes people feel better, and may do more than that.

I learned this once in a hospice fifteen years ago and then let it fade into a nice story about my training. It took my mother's cough, and a question from a machine, to make me actually use it.

---

How this piece was built

I started with a brain dump. I talked out the whole story, unstructured and unedited: the hospice moonlighting, my mother's cough, the AI query, the palliative care visit, what changed. Then I handed that raw transcript to Claude (Anthropic) and worked with it to turn the material into this piece.

AI disclosure. The experience, the argument, and the point of view are mine. Claude searched PubMed, Consensus, and the WHO for the peer-reviewed evidence cited here and verified every trial number against the source abstract, produced both figures, structured the narrative from my spoken brain dump, and helped me tighten the draft. I directed the framing, supplied the experience, and reviewed every claim, number, and citation before publishing. Separately, I used OpenEvidence during my mother's care to prepare questions for her oncology team, which is how the palliative care referral came up in the first place.

References

1. Temel JS, et al. Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med. 2010;363(8):733-742. doi:10.1056/NEJMoa1000678
2. Sanders JJ, et al. Palliative care for patients with cancer: ASCO guideline update. J Clin Oncol. 2024;42(19):2336-2357. doi:10.1200/JCO.24.00542
3. Kavalieratos D, et al. Association between palliative care and patient and caregiver outcomes: a systematic review and meta-analysis. JAMA. 2016;316(20):2104-2114. doi:10.1001/jama.2016.16840
4. Haun MW, et al. Early palliative care for adults with advanced cancer. Cochrane Database Syst Rev. 2017;6(6):CD011129. doi:10.1002/14651858.CD011129.pub2
5. Bakitas MA, et al. Early versus delayed initiation of concurrent palliative oncology care: patient outcomes in the ENABLE III randomized controlled trial. J Clin Oncol. 2015;33(13):1438-1445. doi:10.1200/JCO.2014.58.6362
6. Zimmermann C, et al. Early palliative care for patients with advanced cancer: a cluster-randomised controlled trial. Lancet. 2014;383(9930):1721-1730. doi:10.1016/S0140-6736(13)62416-2
7. Rogers JG, et al. Palliative care in heart failure: the PAL-HF randomized, controlled clinical trial. J Am Coll Cardiol. 2017;70(3):331-341. doi:10.1016/j.jacc.2017.05.030
8. Greer JA, et al. Telehealth vs in-person early palliative care for patients with advanced lung cancer: a multisite randomized clinical trial. JAMA. 2024;332(14):1153-1164. doi:10.1001/jama.2024.13964
9. Temel JS, et al. Stepped palliative care for patients with advanced lung cancer: a randomized clinical trial. JAMA. 2024;332(6):471-481. doi:10.1001/jama.2024.10398
10. Harle A, et al. A cross sectional study to determine the prevalence of cough and its impact in patients with lung cancer: a patient unmet need. BMC Cancer. 2020;20(1):9. doi:10.1186/s12885-019-6451-1
11. Trivedi N, et al. Awareness of palliative care among a nationally representative sample of U.S. adults. J Palliat Med. 2019;22(12):1578-1582. doi:10.1089/jpm.2018.0656
12. Langan E, et al. Comparing palliative care knowledge in metropolitan and nonmetropolitan areas of the United States: results from a national survey. J Palliat Med. 2021;24(12):1833-1839. doi:10.1089/jpm.2021.0114
13. World Health Organization. Palliative care fact sheet. 2020. who.int

Peer-reviewed sources were located through PubMed and Consensus. Nothing in this post describes anyone's protected health information beyond what my family has chosen to share.